Insurtech companies have been among the biggest victims of the public market selloff, especially those that went public in 2021. Notably, Metromile saw its valuation decline over 85% and was subsequently acquired by peer Lemonade, and it hasn’t been alone in losing a lot of value and being eyed by peers and incumbents.
All this M&A activity and repricing in the public insurtech cohort left us wondering about their private peers: Are the same trends at play, and to what extent?
Investors across North America and Europe agreed that while insurtech has suffered as investors sought out m
コメント